Scarica l'app Stockscreener
127.96
0.75%
-0.97
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché KMB Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$128.93
Aprire:
$128.85
Volume 24 ore:
3.09M
Relative Volume:
1.35
Capitalizzazione di mercato:
$44.14B
Reddito:
$19.75B
Utile/perdita netta:
$2.47B
Rapporto P/E:
17.43
EPS:
7.34
Flusso di cassa netto:
$2.39B
1 W Prestazione:
-3.68%
1M Prestazione:
-7.99%
6M Prestazione:
-1.85%
1 anno Prestazione:
-9.68%
Intervallo 1D:
$127.76
$129.16
Intervallo di 1 settimana:
$127.76
$134.00
Portata 52W:
$124.10
$150.45
Kimberly Clark Corp Stock (KMB) Company Profile
Nome
Kimberly Clark Corp
Settore
Industria
Telefono
(972) 281-1200
Indirizzo
351 PHELPS DRIVE, IRVING, TX
Confronta KMB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
KMB
Kimberly Clark Corp
|
127.96 | 44.14B | 19.75B | 2.47B | 2.39B | 7.34 |
|
PG
Procter Gamble Co
|
158.02 | 381.79B | 83.93B | 15.50B | 15.03B | 6.30 |
|
UL
Unilever Plc Adr
|
62.10 | 154.84B | 65.10B | 6.16B | 0 | 2.4569 |
|
CL
Colgate Palmolive Co
|
88.19 | 74.51B | 19.95B | 2.90B | 3.47B | 3.54 |
|
KVUE
Kenvue Inc
|
21.36 | 41.32B | 15.30B | 1.06B | 1.45B | 0.55 |
Kimberly Clark Corp Stock (KMB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-08 | Downgrade | TD Cowen | Buy → Hold |
| 2024-07-23 | Iniziato | TD Cowen | Buy |
| 2024-06-24 | Iniziato | Exane BNP Paribas | Neutral |
| 2024-06-13 | Aggiornamento | BofA Securities | Underperform → Buy |
| 2024-06-03 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-03-28 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2024-03-01 | Ripresa | Goldman | Buy |
| 2023-12-15 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-11-17 | Iniziato | Piper Sandler | Overweight |
| 2023-10-12 | Aggiornamento | Bernstein | Underperform → Mkt Perform |
| 2023-09-22 | Iniziato | HSBC Securities | Hold |
| 2023-03-20 | Aggiornamento | Deutsche Bank | Sell → Hold |
| 2023-02-17 | Iniziato | Citigroup | Sell |
| 2023-01-04 | Downgrade | Jefferies | Buy → Hold |
| 2022-12-06 | Downgrade | Deutsche Bank | Hold → Sell |
| 2022-10-18 | Iniziato | Evercore ISI | In-line |
| 2022-10-12 | Aggiornamento | Atlantic Equities | Neutral → Overweight |
| 2022-09-14 | Ripresa | BofA Securities | Neutral |
| 2022-02-02 | Downgrade | Bernstein | Mkt Perform → Underperform |
| 2022-01-27 | Reiterato | Citigroup | Sell |
| 2022-01-27 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2022-01-27 | Reiterato | UBS | Neutral |
| 2022-01-27 | Reiterato | Wells Fargo | Equal Weight |
| 2022-01-11 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| 2021-10-26 | Downgrade | Berenberg | Buy → Hold |
| 2021-09-09 | Iniziato | HSBC Securities | Hold |
| 2021-06-24 | Iniziato | UBS | Neutral |
| 2021-05-14 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2021-03-19 | Downgrade | JP Morgan | Neutral → Underweight |
| 2021-01-26 | Downgrade | Argus | Buy → Hold |
| 2021-01-20 | Iniziato | Bernstein | Mkt Perform |
| 2020-12-08 | Iniziato | Wells Fargo | Underweight |
| 2020-10-16 | Iniziato | Berenberg | Buy |
| 2020-10-16 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-03-30 | Aggiornamento | Jefferies | Hold → Buy |
| 2019-10-23 | Aggiornamento | Deutsche Bank | Sell → Hold |
| 2019-09-27 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-09-23 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2019-07-24 | Aggiornamento | Atlantic Equities | Underweight → Neutral |
| 2019-06-19 | Reiterato | BofA/Merrill | Neutral |
| 2019-04-23 | Aggiornamento | Argus | Hold → Buy |
| 2019-04-23 | Aggiornamento | Macquarie | Neutral → Outperform |
| 2019-02-11 | Iniziato | Exane BNP Paribas | Outperform |
| 2019-01-24 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2019-01-18 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-10-08 | Downgrade | Goldman | Buy → Neutral |
| 2018-09-20 | Iniziato | Atlantic Equities | Underweight |
| 2018-08-16 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2018-08-15 | Downgrade | Societe Generale | Buy → Hold |
| 2018-06-21 | Iniziato | Morgan Stanley | Underweight |
| 2017-12-14 | Iniziato | Deutsche Bank | Hold |
Mostra tutto
Kimberly Clark Corp Borsa (KMB) Ultime notizie
The 5 Most Interesting Analyst Questions From Kimberly-Clark’s Q1 Earnings Call - Yahoo Finance
How Cadence Bank, Kimberly-Clark, And Robert Half Can Put Cash In Your Pocket - Yahoo Finance
Incontinence Pads Market Top PlayersCardinal Health Inc., - openPR.com
Kimberly-Clark Sells Global Tissue Unit in $3.4 Billion Deal - MSN
Warren Approves JEDD for Kimberly-Clark Project - Business Journal Daily
Warren, Howland Plan Public Hearings on Kimberly-Clark JEDD - Business Journal Daily
How Is Kimberly-Clark's Stock Performance Compared to Other Consumer Defensive Stocks? - Barchart.com
An Empire Built on Paper Looks to Benefit From Trump’s Trade War - Bloomberg.com
Jim Cramer Praises Kimberly-Clark’s (KMB) Deal with Suzano - Insider Monkey
Tesla And Lululemon Are Among Top 10 Large-Cap Losers Last Week (Jun 2-Jun 6): Are The Others In Your Portfolio? - Benzinga
15 Stocks on Jim Cramer’s Radar - Insider Monkey
Kimberly-Clark Nears Global Tissue Business Sale, WSJ Says - MSN
Suzano’s rating outlook revised to positive by S&P after Kimberly-Clark deal - Investing.com South Africa
2 Dividend Kings Reshaping Their Empires—Here's The Hidden Opportunity - 24/7 Wall St.
Suzano & Kimberly-Clark to Form Global Tissue Joint Venture - Nasdaq
Kimberly-Clark: International Tissue Spinoff Unlocks Enhanced Focus on Higher-Margin Personal Care - Morningstar
Kimberly-Clark (KMB) Set to Divest Global Tissue Unit to Refocus Portfolio - MSN
Kimberly-Clark Teams Up With Suzano In $3.4 Billion Venture - Finimize
Kimberly-Clark Nears $3.5 Billion Sale of International Tissue B - GuruFocus
Kimberly-Clark to sell international Kleenex business, other tissue assets for $3.4 billion - The Business Journals
Kimberly-Clark Sells Stake in $3.4B Tissue Business to Suzano - USA Herald
Suzano stock soars on joint venture news; Kimberly-Clark dips - Investing.com
Tissue Titans Unite: Suzano, Kimberly-Clark Form $3.4 Billion Global JV - Benzinga
Kimberly-Clark (KMB) Announces Strategic Joint Venture with Suzano S.A. - GuruFocus
Kimberly-Clark To Sell Majority of $3.4B Global Tissue Business - Yahoo Finance
Irving-based Kimberly-Clark selling international arm for $3.4B - Dallas News
Kimberly-Clark Points Downward on Suzano Hookup - Baystreet.ca
Kimberly-Clark (KMB) Partners with Suzano for Global Tissue Vent - GuruFocus
suzano announces joint venture with kimberly-clark - Investing.com
Kimberly-Clark and Suzano form a new global tissue company that plays to their strengths (KMB:NASDAQ) - Seeking Alpha
Kimberly-Clark sells majority stake in international tissue unit to Brazil's Suzano - CNBC
Kimberly-Clark forms strategic partnership with Suzano for tissue and professional products - Investing.com
Suzano and Kimberly-Clark form $3.4 billion tissue venture - Investing.com
Kimberly-Clark to form partnership with Suzano - TipRanks
Kimberly-Clark (KMB) Forms Strategic Alliance with Suzano | KMB Stock News - GuruFocus
Kimberly-Clark to sell international tissue business in $3.4 billion deal By Reuters - Investing.com
Massive $3.4B Deal: Suzano Acquires 51% of Kleenex International Operations Across 70 Countries - Stock Titan
Kimberly-Clark to spin off Kleenex and other tissue products outside US - Financial Times
Kimberly-Clark's $3.4B Deal: Major Shift to High-Margin Personal Care as Tissue Unit Joins Suzano - Stock Titan
Kimberly-Clark (KMB) Nears Sale of Kleenex Division Outside Nort - GuruFocus
Kimberly-Clark (KMB) Nears Sale of Kleenex Division Outside North America | KMB Stock News - GuruFocus
Kimberly-Clark close to $3.5B sale of international Kleenex business, WSJ says - TipRanks
American National Bank & Trust Trims Holdings in Kimberly-Clark Co. (NYSE:KMB) - MarketBeat
Kimberly-Clark Co. (NYSE:KMB) Shares Acquired by Allied Investment Advisors LLC - MarketBeat
Kimberly-Clark Nears $3.5 Billion Sale of International Tissue Business - GuruFocus
Kimberly-Clark nears sale of Kleenex division outside North America for $3.5 billionreport - Investing.com
Kimberly-Clark (KMB) Nears $3.5B Sale of Tissue Business to Suza - GuruFocus
Kimberly-Clark nears $3.5B sale of international tissue business to SuzanoWSJ (KMB:NASDAQ) - Seeking Alpha
Kimberly-Clark nears $3.5 billion sale of global tissue business to Suzano, WSJ reports By Reuters - Investing.com
Kimberly Clark Corp Azioni (KMB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Kimberly Clark Corp Azioni (KMB) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Chen Katy | President, Int'l Personal Care |
May 02 '25 |
Sale |
129.70 |
740 |
95,978 |
3,997 |
| Drexler Andrew | Vice President and Controller |
May 01 '25 |
Option Exercise |
0.00 |
654 |
0 |
9,445 |
| Urdaneta Nelson | Chief Financial Officer |
May 01 '25 |
Option Exercise |
0.00 |
3,188 |
0 |
28,856 |
| Torres Russell | President, North America |
May 01 '25 |
Option Exercise |
0.00 |
3,006 |
0 |
68,078 |
| McGee Grant B | General Counsel & Secretary |
May 01 '25 |
Option Exercise |
0.00 |
1,093 |
0 |
3,101 |
| Melucci Jeffrey P. | Chief Bus., Strat. & Transf. |
May 01 '25 |
Option Exercise |
0.00 |
2,869 |
0 |
48,132 |
| Karrmann Sandra R | Chief People Officer |
May 01 '25 |
Option Exercise |
0.00 |
1,138 |
0 |
25,941 |
| Hicks Zackery A | Chief Digital & Technology Off |
May 01 '25 |
Option Exercise |
0.00 |
2,733 |
0 |
8,804 |
| Abou-Oaf Ehab | Pres. Int'l Fam. Care & Prof. |
May 01 '25 |
Option Exercise |
0.00 |
1,366 |
0 |
40,909 |
| Fenske Tamera | Chief Supply Chain Officer |
May 01 '25 |
Option Exercise |
0.00 |
1,366 |
0 |
6,779 |
0.37%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):